Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL726P is a human pseudogene derived from the 7SL RNA gene, which is the RNA component of the signal recognition particle (SRP) complex essential for protein targeting to the endoplasmic reticulum. Unlike the functional 7SL RNA, the RN7SL726P pseudogene is a non-functional, truncated genomic sequence resulting from the reverse flow of genetic information from 7SL RNA back into DNA. The majority of 7SL-like sequences in human DNA are pseudogenes and are generally not transcribed or do not have a known function in normal physiology. However, the broader class of pseudogenes may sometimes have regulatory roles or affect gene expression under certain contexts[1][6][7][2][4]. There is no evidence that RN7SL726P serves as a therapeutic target, drug receptor, or biomarker. The presence of "pseudogene" in its name and the lack of functional protein expression indicate that this is not a canonical molecular target but rather a genomic relic with no established direct role in human health or disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 7SL RNA pseudogene 726, cytoplasmic (RN7SL726P).